Catalyst Wire Dossier Catalyst Wire Dossier

XTL 2125

· Hadassah Medical Organization
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XTL 2125, covering 2007-11-06 to 2007-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers [Phase 1]

See pricing